Sowell Financial Services LLC increased its holdings in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 1,652.0% in the third quarter, Holdings Channel.com reports. The firm owned 142,492 shares of the biotechnology company’s stock after acquiring an additional 134,359 shares during the period. Axon Enterprise makes up approximately 1.9% of Sowell Financial Services LLC’s investment portfolio, making the stock its 7th biggest position. Sowell Financial Services LLC’s holdings in Axon Enterprise were worth $60,206,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds also recently made changes to their positions in the business. Ascent Wealth Partners LLC lifted its stake in Axon Enterprise by 308.2% in the third quarter. Ascent Wealth Partners LLC now owns 66,568 shares of the biotechnology company’s stock worth $28,126,000 after purchasing an additional 50,260 shares during the last quarter. Evergreen Capital Management LLC grew its stake in shares of Axon Enterprise by 3,745.6% during the third quarter. Evergreen Capital Management LLC now owns 45,647 shares of the biotechnology company’s stock valued at $19,287,000 after buying an additional 44,460 shares during the last quarter. Manchester Capital Management LLC grew its stake in shares of Axon Enterprise by 40,610.5% during the third quarter. Manchester Capital Management LLC now owns 7,735 shares of the biotechnology company’s stock valued at $3,268,000 after buying an additional 7,716 shares during the last quarter. Barrett & Company Inc. grew its stake in shares of Axon Enterprise by 2,250.7% during the third quarter. Barrett & Company Inc. now owns 6,582 shares of the biotechnology company’s stock valued at $2,781,000 after buying an additional 6,302 shares during the last quarter. Finally, Farmers & Merchants Investments Inc. increased its holdings in shares of Axon Enterprise by 627,002.2% in the third quarter. Farmers & Merchants Investments Inc. now owns 282,196 shares of the biotechnology company’s stock worth $119,233,000 after buying an additional 282,151 shares during the period. Institutional investors own 79.08% of the company’s stock.
Insider Activity at Axon Enterprise
In other news, insider Isaiah Fields sold 1,017 shares of the firm’s stock in a transaction dated Friday, September 11th. The shares were sold at an average price of $480.45, for a total value of $488,617.65. Following the completion of the sale, the insider directly owned 56,264 shares of the company’s stock, valued at approximately $27,032,038.80. This trade represents a 1.78% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Patrick W. Smith sold 10,000 shares of the firm’s stock in a transaction dated Tuesday, September 8th. The stock was sold at an average price of $508.99, for a total transaction of $5,089,900.00. Following the completion of the sale, the chief executive officer directly owned 3,118,012 shares of the company’s stock, valued at approximately $1,587,036,927.88. This represents a 0.32% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 47,397 shares of company stock valued at $26,722,984 in the last 90 days. 4.20% of the stock is owned by company insiders.
Axon Enterprise Price Performance
Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The biotechnology company reported $1.88 EPS for the quarter, topping analysts’ consensus estimates of $1.84 by $0.04. The company had revenue of $904.39 million during the quarter, compared to analyst estimates of $876.42 million. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%. The firm’s revenue was up 35.3% on a year-over-year basis. During the same quarter last year, the firm posted $2.12 earnings per share. On average, equities research analysts predict that Axon Enterprise, Inc will post 2.10 EPS for the current year.
Analyst Ratings Changes
A number of research firms have recently weighed in on AXON. Argus boosted their target price on Axon Enterprise from $460.00 to $600.00 and gave the company a “buy” rating in a research note on Thursday, September 3rd. Zacks Research upgraded Axon Enterprise from a “hold” rating to a “strong-buy” rating in a research report on Monday, October 5th. Piper Sandler reduced their price target on Axon Enterprise from $732.00 to $561.00 and set an “overweight” rating on the stock in a research report on Tuesday, October 20th. Needham & Company LLC reaffirmed a “buy” rating on shares of Axon Enterprise in a research note on Tuesday. Finally, The Goldman Sachs Group lowered their price objective on Axon Enterprise from $715.00 to $675.00 and set a “buy” rating for the company in a research report on Monday, September 21st. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat, Axon Enterprise has a consensus rating of “Moderate Buy” and a consensus price target of $688.38.
Check Out Our Latest Stock Analysis on AXON
Axon Enterprise Profile
Axon Enterprise, Inc develops technology and connected products for public safety organizations. The company’s portfolio includes TASER conducted-energy weapons, body-worn cameras, in-car cameras, and related hardware designed to support law enforcement, corrections, security, and other emergency-response professionals.
Axon also provides cloud-based software for managing digital evidence, records, workflows, real-time operations, investigations, and communications. Its platform is intended to connect hardware, software, and services across the public-safety ecosystem, helping agencies collect, store, analyze, and share operational information.
The company was founded in 1993 as TASER International by Rick Smith and Tom Smith and adopted the name Axon Enterprise in 2017 as it expanded beyond conducted-energy weapons into a broader technology platform.
Read More
- Five stocks we like better than Axon Enterprise
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
- Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
- Why Tesla’s Upside Is About More Than a SpaceX Merger
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
